ha, you're welcome - you may have just bought the bargain of the century. I do think 2016 will be the year for HEB. While the delay in alferon manufacturing has been disappointing, it is a complicated process.... the good news is, that the process works... they've got a batch filled and finished and another one waiting to be filled and finished. It will be interesting to see if they sell these batches to the EU.
I was very glad to see them fill the Flumist/ampligen phase II part of the trial (a fellow investor called UAB to confirm this) as this is where there is absolutely huge potential... down the line a bit, 3-5 years.
Market Data 
Markets 
AI
